Clincosm LogoSign in Get a demo

hepatitis c infection

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

Recruiting
  • Hepatitis C Infection
  • HIV Infection
  • Glecaprevir/Pibrentasvir (G/P)
  • Ribavirin (RBV)
  • San Diego, California
  • +15 more
Dec 19, 2022

Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir

Not yet recruiting
  • Hepatitis C Infection
    • Beijing, Bejing, China
      Bejing Tsinghua Changgung Hospital
    Oct 31, 2022

    Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

    Active, not recruiting
    • Chronic Hepatitis
    • Hepatitis C Infection
    • Electroporation-Mediated Plasmid DNA Vaccine Therapy
    • +4 more
    • Jacksonville, Florida
    • +4 more
    Sep 20, 2022

    HCV Care and Treatment for HIV-HCV Co-infected Decentralised

    Not yet recruiting
    • HIV Infection
    • Hepatitis C Infection
    • Blood samples
    • Vinh, Nghe An, Vietnam
    • +1 more
    Aug 16, 2022

    HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

    Completed
    Has Results
    • HIV Infection
    • Hepatitis C Infection
    • Nitazoxanide (NTZ)
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Nov 2, 2021

    Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

    Completed
    Has Results
    • Hepatitis C Infection
    • HIV Infection
    • Nitazoxanide With Pegylated Interferon And Ribavirin
    • Washington, District of Columbia
    • +3 more
    Sep 14, 2021

    People Living With Hepatitis C in Vietnam

    Recruiting
    • Hepatitis C Infection
    • Clinical examination
    • Nîmes, France
    • +1 more
    Aug 6, 2021

    Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

    Completed
    Has Results
    • Hepatitis C Infection
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))

    Terminated
    Has Results
    • Hepatitis C Infection
    • MBL-HCV1
    • +2 more
    • Boston, Massachusetts
    • +4 more
    Feb 4, 2021

    Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

    Completed
    Has Results
    • Hepatitis C Infection
    • (no location specified)
    Jan 15, 2021

    Hepatitis C Infection, Depression Trial in Netherlands (Paroxetine, telaprevir)

    Terminated
    • Hepatitis C Infection
    • Depression
    • Amsterdam, Netherlands
    • +6 more
    Dec 4, 2020

    Hepatitis C Infection Trial in New York (Recombivax)

    Terminated
    Has Results
    • Hepatitis C Infection
    • New York, New York
      Rockefeller University Hospital
    Feb 20, 2020

    Hepatitis C Infection Trial in Australia, New Zealand (SB9200, Placebo)

    Completed
    • Hepatitis C Infection
    • Heidelberg, Victoria, Australia
    • +3 more
    Sep 17, 2019

    Hepatitis C Infection, HIV Trial in Thailand (Peg-interferon + ribavirin under HIV physician supervision)

    Completed
    Has Results
    • Hepatitis C Infection
    • HIV
    • Peg-interferon + ribavirin under HIV physician supervision
    • San Pa Tong, Chiang Mai, Thailand
    • +4 more
    Feb 22, 2019

    Liver Disease and Without HIV Co-infection-Sub Study 2: HCV

    Completed
    • Hepatitis C Infection
      • New York, New York
        Icahn School of Medicine
      Feb 25, 2019

      Hepatitis C Infection in World Trade Center Responders

      Completed
      • Hepatitis C Infection
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Feb 1, 2019

        Hepatitis C Infection Trial (Ruzasvir)

        Completed
        Has Results
        • Hepatitis C Infection
        • (no location specified)
        Dec 3, 2018

        Hepatitis C Infection, HIV Infection Trial in Oxford (AdCh3NSmut1, MVA-NSmut, ChAdV63.HIVconsv)

        Completed
        • Hepatitis C Infection
        • HIV Infection
        • AdCh3NSmut1
        • +3 more
        • Oxford, Oxfordshire, United Kingdom
          Centre for Clinical Vaccinology and Tropical Medicine
        Oct 10, 2018

        Hepatitis C Infection Trial in Dublin, St. Gallen (AdCh3NSmut1, MVA-NSmut)

        Completed
        • Hepatitis C Infection
        • AdCh3NSmut1
        • MVA-NSmut
        • Dublin, Ireland
        • +1 more
        Oct 10, 2018

        Adult Primary Liver Cancer, Hepatitis C Infection Trial in United States (S-adenosyl-L-methionine disulfate p-toluene-sulfonate,

        Completed
        Has Results
        • Adult Primary Liver Cancer
        • Hepatitis C Infection
        • S-adenosyl-L-methionine disulfate p-toluene-sulfonate
        • +4 more
        • Tucson, Arizona
        • +4 more
        Aug 9, 2018

        Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks

        Completed
        • Hepatitis C Infection
        • ombitasvir/paritaprevir/ritonavir 8 weeks
        • dasabuvir 8 weeks
        • Barcelona, Spain
          Carrion, Jose Antonio, PhD
        May 18, 2018

        Hepatitis C Infection Trial in New York (ITX 5061)

        Terminated
        • Hepatitis C Infection
        • ITX 5061
        • New York, New York
          Mount Sinai School of Medicine
        Apr 16, 2018

        Hepatitis C Infection Trial in Puerto Rico, United States (Placebo, SCY-635, Pegasys)

        Completed
        Has Results
        • Hepatitis C Infection
        • Placebo
        • +3 more
        • San Francisco, California
        • +3 more
        Jul 18, 2017

        Hepatitis C Infection, Thrombocytopenia Trial in Los Angeles (biological, drug, other)

        Terminated
        • Hepatitis C Infection
        • Thrombocytopenia
        • romiplostim
        • +4 more
        • Los Angeles, California
          USC/Norris Comprehensive Cancer Center
        Apr 9, 2017